{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:56:32Z","timestamp":1768467392021,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["2017\/25\/B\/NZ7\/01096"],"award-info":[{"award-number":["2017\/25\/B\/NZ7\/01096"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Polish Academy of Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pbb.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T10:27:37Z","timestamp":1554546457000},"page":"17-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment"],"prefix":"10.1016","volume":"181","author":[{"given":"Agnieszka","family":"W\u0105sik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bia\u0142o\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelina","family":"\u017barnowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucyna","family":"Antkiewicz-Michaluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb9000","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euroneuro.2004.11.005","article-title":"Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain","volume":"15","author":"Angelucci","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2006.03756.x","article-title":"The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity","volume":"97","author":"Antkiewicz-Michaluk","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2019.04.002_bb0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00702-006-0546-y","article-title":"An endogenous neuroprotectant substancje, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats","volume":"114","author":"Antkiewicz-Michaluk","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pbb.2019.04.002_bb0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2008.09.033","article-title":"3-Methoxytyramine, an extraneuronal dopamine metabolite plays a physiological role in the brain as an inhibitory regulator of catecholaminergic activity","volume":"599","author":"Antkiewicz-Michaluk","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2019.04.002_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-013-9402-7","article-title":"1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application","volume":"25","author":"Antkiewicz-Michaluk","year":"2014","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-009-0082-5","article-title":"Extrastriatal dopamine D2 receptor occupancy in olanzapine-treated patients with schizophrenia","volume":"260","author":"Arakawa","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01340-1","article-title":"Effects of ketamine on different types of anxiety","volume":"431","author":"Babar","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia","volume":"27","author":"Becker","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2019.04.002_bb0040","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4149\/BLL_2017_119","article-title":"The protective effect of thymoquinone over olanzapine-induced side effects in liver, and metabolic side effects","volume":"118","author":"Bilgic","year":"2017","journal-title":"Bratisl. Med. J."},{"issue":"1","key":"10.1016\/j.pbb.2019.04.002_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2013.07.030","article-title":"Anxiety comorbidity in schizophrenia","volume":"210","author":"Braga","year":"2013","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.pbb.2019.04.002_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0024-3205(83)90707-5","article-title":"Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine","volume":"33","author":"Charney","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2019.04.002_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneumeth.2014.08.006","article-title":"A computational model for exploratory activity of rats with different anxiety levels in elevated plus-maze","volume":"236","author":"Costa","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pbb.2019.04.002_bb0060","doi-asserted-by":"crossref","unstructured":". da Silva F. C., do Carmo de Oliveira Cito, M., da Silva M. I., Moura B. A., de Aquino Neto M. R., Feitosa M. L., de Castro Chaves R., Macedo D. S., de Vasconcelos S. M., de Fran\u00e7a Fonteles M. M., de Sousa F. C., 2010. Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res. Bull. 83 (1\u20132), 9\u201315.","DOI":"10.1016\/j.brainresbull.2010.05.011"},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"Deakin","year":"1991","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-013-3048-2","article-title":"Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1\/D5 receptors","volume":"228","author":"Duan","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.04.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6817349","article-title":"Genesis and maintenance of attentional biases: the role of the locus coeruleus-noradrenaline system","volume":"2017","author":"Ehlers","year":"2017","journal-title":"Neural Plast."},{"issue":"5","key":"10.1016\/j.pbb.2019.04.002_bb0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0447.1995.tb09596.x","article-title":"Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study","volume":"92","author":"Fahlen","year":"1995","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2019.04.002_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2739\/kurumemedj.30.31","article-title":"Effects of altered brain noradrenaline level on acute stress pathology in rats","volume":"30","author":"Glavin","year":"1983","journal-title":"Kurume Med. J."},{"issue":"1","key":"10.1016\/j.pbb.2019.04.002_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","article-title":"Role of 5-HT in stress, anxiety, and depression","volume":"54","author":"Graeff","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.pbb.2019.04.002_bb0100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50\u202fyears of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Net. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.pbb.2019.04.002_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/FBP.0000000000000394","article-title":"Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats","volume":"29","author":"Horsley","year":"2018","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2019.04.002_bb0115","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1523\/JNEUROSCI.3800-04.2005","article-title":"Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats","volume":"25","author":"Hunt","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2019.04.002_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2010.12.012","article-title":"Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway","volume":"177","author":"Kamiyama","year":"2011","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pbb.2019.04.002_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00000542-197702000-00001","article-title":"Effects of pharmacologic alterations of adrenergic mechanisms by cocaine, tropolone, aminophylline, and ketamine on epinephrine-induced arrhythmias during halothane-nitrous oxide anesthesia","volume":"46","author":"Koehntop","year":"1977","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2019.04.002_bb0135","article-title":"Olanzapine versus other atypical antipsychotics for schizophrenia","volume":"17","author":"Komossa","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pbb.2019.04.002_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130051049","article-title":"Interactive effects of subanesthetic ketamine and haloperidol an healthy humans","volume":"145","author":"Krystal","year":"1999","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.pbb.2019.04.002_bb0145","first-page":"579","article-title":"Anxiolytic effects of venlafaxine\/olanzapine combination in treatment of anxious depression","volume":"38","author":"Kulhan","year":"2018","journal-title":"Neuro Endocrinol. Lett."},{"issue":"6","key":"10.1016\/j.pbb.2019.04.002_bb0150","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1734-1140(10)70366-2","article-title":"1-Methyl-1,2,3,4-tetrahydroisoquinoline and established uncompetitive NMDA receptor antagonists induce tolerance to excitotoxicity","volume":"62","author":"Kuszczyk","year":"2010","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12640-013-9440-1","article-title":"1MeTIQ provides protection against A\u03b2-induced reduction of surface expression of synaptic proteins and inhibits H\u2082O\u2082-induced oxidative stress in primary hippocampal neurons","volume":"25","author":"Kuszczyk","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pbb.2019.04.002_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2013.08.005","article-title":"Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density","volume":"47","author":"Lian","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb0165","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.pbb.2019.04.002_bb0170","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1139\/y81-078","article-title":"Ketamine potentiates catecholamine responses of vascular smooth muscle by inhibition of extraneuronal uptake","volume":"59","author":"Lundy","year":"1981","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb9005","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuron.2015.07.002","article-title":"CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety","volume":"87","author":"McCall","year":"2015","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.pbb.2019.04.002_bb0175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/1389557515666150219125030","article-title":"Benzo- and thienobenzo-diazepines: multi target drugs for CNS disorders","volume":"15","author":"Mendonca J\u00f9nior","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.pbb.2019.04.002_bb0180","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.pnpbp.2005.08.007","article-title":"Role of brain norepinephrine in the behavioral response to stress","volume":"29","author":"Morilak","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0185","first-page":"666","article-title":"Olanzapine","volume":"71","author":"Nagai","year":"2013","journal-title":"Nihon Rinsho"},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00213-011-2297-1","article-title":"The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration","volume":"217","author":"Nikiforuk","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.04.002_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-244X-14-145","article-title":"Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study","volume":"14","author":"Pan","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pbb.2019.04.002_bb0200","first-page":"727","article-title":"Inhibition of the rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds-1,2,3,4-tetrahydroisoquinoline alkaloids","volume":"56","author":"Patsenka","year":"2004","journal-title":"Pol. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.pbb.2019.04.002_bb0205","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.pnpbp.2006.02.019","article-title":"Ketamine administration disturbs behavioural and distributed neural correlates of fear conditioning in the rat","volume":"30","author":"Pietersen","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.04.002_bb0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbr.2018.03.012","article-title":"Lateral habenular norepinephrine contributes to states of arousal and anxiety in male rats","volume":"347","author":"Purvis","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2019.04.002_bb0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pharep.2015.10.010","article-title":"The influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) expose to the ethyl alcohol","volume":"68","author":"Ratajczak","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2019.04.002_bb0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.etap.2016.07.007","article-title":"The influence of aripiprazole and olanzapine on neurotransmitters level in front al cortex of prenatally stressed rats","volume":"46","author":"Ratajczak","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.pbb.2019.04.002_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ntt.2016.02.004","article-title":"Distinct effects of ketamine and acetyl l-carnitine on the dopamine system in zebrafish","volume":"54","author":"Robinson","year":"2016","journal-title":"Neurotoxicol. Teratol."},{"issue":"6","key":"10.1016\/j.pbb.2019.04.002_bb0230","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S1734-1140(11)70719-8","article-title":"Anxiolytic-like effects of olanzapine, risperidone and fluoxetine in the elevated plus-maze test in rats","volume":"63","author":"Rog\u00f3\u017c","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.pbb.2019.04.002_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0","article-title":"Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats","volume":"5","author":"Silvestre","year":"1997","journal-title":"Depress. Anxiety"},{"issue":"36","key":"10.1016\/j.pbb.2019.04.002_bb0250","article-title":"Anxiety, irritability and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials","volume":"5","author":"Suppes","year":"2017","journal-title":"Int. J. Bipolar Disord."},{"issue":"19","key":"10.1016\/j.pbb.2019.04.002_bb0255","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/0024-3205(82)90499-4","article-title":"Naloxone enhances stress-induced increases in noradrenaline turnover in specific brain regions in rats","volume":"30","author":"Tanaka","year":"1982","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb0260","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0091-3057(83)90132-6","article-title":"Regional characteristics of stress-induced increases in brain noradrenaline release in rats","volume":"19","author":"Tanaka","year":"1983","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"117","key":"10.1016\/j.pbb.2019.04.002_bb0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1254\/jjp.37.117","article-title":"Methionine-enkephalin inhibits stress-induced increases in noradrenaline turnover in brain regions of rats","volume":"37","author":"Tanaka","year":"1985","journal-title":"Jpn. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2019.04.002_bb0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0014-2999(00)00569-0","article-title":"Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies","volume":"405","author":"Tanaka","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2019.04.002_bb0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0924-977X(92)90032-4","article-title":"Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor","volume":"2","author":"Van Vliet","year":"1992","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2019.04.002_bb0275","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1192\/bjp.161.3.353","article-title":"Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine","volume":"161","author":"Versiani","year":"1992","journal-title":"Brit. J. Psychiat."},{"key":"10.1016\/j.pbb.2019.04.002_bb0280","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nn1846","article-title":"Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory","volume":"10","author":"Vijayraghavan","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0290","doi-asserted-by":"crossref","first-page":"265","DOI":"10.31887\/DCNS.2001.3.4\/fxvollenweider","article-title":"Brain mechanisms of hallucinogens and entactogens","volume":"3","author":"Vollenweider","year":"2001","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.pbb.2019.04.002_bb0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/10253890.2011.607525","article-title":"Dopamine D1 receptors are responsible for stress-induced emotional memory deficit in mice","volume":"15","author":"Wang","year":"2012","journal-title":"Stress"},{"issue":"6","key":"10.1016\/j.pbb.2019.04.002_bb0300","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1734-1140(10)70360-1","article-title":"Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study","volume":"62","author":"W\u0105sik","year":"2010","journal-title":"Pharmacol. Rep."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2019.04.002_bb0305","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2012.11.063","article-title":"Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: a comparison with the classical antidepressant, imipramine","volume":"700","author":"W\u0105sik","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0310","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12640-013-9425-0","article-title":"1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neuroprotectant and MAO inhibitor with antidepressant-like properties in the rat","volume":"25","author":"W\u0105sik","year":"2014","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.pbb.2019.04.002_bb0315","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12640-016-9661-1","article-title":"Comparison of the effects of acute and chronic administration of tetrahydroisoquinoline amines on the in vivo dopamine release: a microdialysis study in the rat striatum","volume":"30","author":"W\u0105sik","year":"2016","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.pbb.2019.04.002_bb0320","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12640-017-9824-8","article-title":"Multiple administration of endogenous amines TIQ and 1MeTIQ protects against a 6-OHDA-induced essential fall of dopamine release in the rat striatum: in vivo microdialysis study","volume":"33","author":"W\u0105sik","year":"2018","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.pbb.2019.04.002_bb0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09595239600185801","article-title":"Pharmacological properties of ketamine","volume":"15","author":"White","year":"1996","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.pbb.2019.04.002_bb0330","article-title":"Pharmacotherapy for social anxiety disorder (SAnD)","volume":"10","author":"Williams","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"21","key":"10.1016\/j.pbb.2019.04.002_bb0335","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1523\/JNEUROSCI.17-21-08528.1997","article-title":"Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance","volume":"17","author":"Zahrt","year":"1997","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.pbb.2019.04.002_bb0340","first-page":"591","article-title":"The modulatory role of dopamine in anxiety-like behavior","volume":"18","author":"Zarrindast","year":"2015","journal-title":"Arch. Iran. Med."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719300383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719300383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:34:31Z","timestamp":1758774871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305719300383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":66,"alternative-id":["S0091305719300383"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.04.002","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}